Low Rates of Physiologic Testing and Prescription Drug Use for <scp>FC</scp> and <scp>IBS</scp> ‐C in Patients With Inflammatory Bowel Disease
In this cohort of IBD patients with FC or IBS-C, only a minority underwent physiologic testing or were escalated to prescription pharmacologic therapy. Further research is needed to understand whether standard of care practices are being applied for those with constipation in IBD.
Authors
- Sanskriti Varma (ORCID: https://orcid.org/0000-0001-5179-7388)
- Casey J. Silvernale (ORCID: https://orcid.org/0000-0003-2732-6724)
- Quinten Dicken (ORCID: https://orcid.org/0000-0001-7416-5172)
- Kyle Staller (ORCID: https://orcid.org/0000-0003-4925-4290)
- Bharati Kochar (ORCID: https://orcid.org/0000-0002-4476-5713)
Institutions
- Harvard University (US)
- University of Vermont Medical Center (US)
- Massachusetts General Hospital (US)
- Center for Neuro-Oncology (US)
Publication Details
- Journal
- Neurogastroenterology & Motility
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1111/nmo.70161
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health